A Pennsylvania Superior Court recently vacated a $27.6 million jury verdict against medical device manufacturer Zimmer Inc. (Zimmer), and marketing firm Public Communications, Inc. (PCI) in a case that involved Zimmer’s Gender Solutions Knee. The decision, which vacated the verdict on causation grounds, is available here.
Zimmer’s Gender Solutions Knee is a knee replacement device specifically designed and manufactured for women. Zimmer hired PCI to produce a sales video featuring footage of patients who had received the Gender Solutions Knee.
The plaintiff Margo Polett…
Continue reading...
Medical Device
Litigation
Continue reading...
- Product Liability Cases to Watch in 2014 (subscription required)
- Master Complaint Approved for Granuflo Lawsuits Against Fresenius
- DePuy ASR Hip Settlement Requires Registration by Jan. 6
- SimplyThick Lawsuits Over Infant Injuries, Deaths Continue to Mount
- Motion Filed to Modify Zoloft Lawsuit Trial Pool in Federal MDL
- Product Liability Regulation to Watch in 2014 (subscription required)
- Antabloc Manufacturers Get FDA Warning Letter Over IBD Claims
Continue reading...
Litigation
Continue reading...
- NECC Fungal Meningitis Settlement May Result in $100M Payment
- MDL Consolidation for Lipitor Diabetes Lawsuits to be Considered Jan. 30
- J&J Risperdal Whistleblower Made Millions in Settlement
- Generic Fosamax Users Must Give More Details in MDL (subscription required)
- JPML Centralizes Glucosamine False Ad Suits (subscription required)
- Boehringer May Face More Sanctions in Pradaxa MDL (subscription required)
- FDA Permits Last-Resort Iclusig Use After Clinical Trial Deaths (subscription required)
- Proposed Rule – Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial
Continue reading...
Litigation
Continue reading...
- 3rd Circ. Doubts Jurisdiction In Generic-Fosamax Appeal (subscription required)
- Mirena IUD Lawsuit Discovery Continues in New Jersey and MDL
- Abbott Ordered to Produce “Overdue” Docs in Depakote Lawsuits
- J&J Fights Attys’ Pursuit of Confidential Risperdal Docs (subscription required)
- Pain-Pump Seller SJO Lied to Get $10M Policy, Insurer Says (subscription required)
- Stryker Inks 1st Settlements in NJ Hip Implant Suits (subscription required)
- Eli Lilly Defeats Soldier’s Cymbalta “Brain Zap” Suit (subscription required)
- 4th Circ. Questions Basis for Generic-Drug
Continue reading...
Royal Free Hospital in London is conducting a trial of a new medical device to treat liver disease on a group of patients with severe alcohol-related liver failure. Results have already shown that that patients’ liver damage can be reversed, which can dramatically improve a patient’s quality of life. The new device, called an alfapump, is manufactured by the Swiss medical device company Sequana Medical and may radically change the treatment options for patients with severe liver disease in the future.
Liver disease impacts the…
Continue reading...
Continue reading...
Litigation
Continue reading...
- High Court Denies Bid to Review Neurontin RICO Rulings (subscription required)
- Merck Settles Fosamax Jaw-Injury Claims for $28M (subscription required)
- Boehringer Fined $1M For Withholding Docs in MDL (subscription required)
- Expert Testimony Must be Backed By Science, Pa. Court Rules (subscription required)
- High Court Passes on Lupron Labeling Suit (subscription required)
- 1st Circ. Ends Takeda FCA Suit But Limits Scope of Ruling (subscription required)
- Medtronic Escapes Jury’s $18M Surgical Fire Verdict (subscription required)
- J&J Keeps Vaginal Mesh Suit Out of
Continue reading...
The FDA quickly addressed a recent report that European health regulators have ordered a label change on an emergency contraceptive product sold by French drugmaker HRA Pharma under the brand name Norlevo(levonorgestrel). The European authorities now require the drug’s labeling to address the potential that there is diminishing effectiveness of the pill depending upon the weight of the user. According to HRA, the emergency contraceptive begins to lose its effectivness for wormn who weigh more than 165 pounds and is completely ineffective for women…
Continue reading...
Continue reading...
Litigation
Continue reading...
- Pamlab Can’t Bar Virtus’ Marketing In Unfair Competition Row (subscription required)
- Pa. Appeals Court Upholds GSK Win in Paxil Pregnancy Suit (subscription required)
- J&J Asks Pa. Court to Keep Risperdal Docs Under Seal (subscription required)
- Standing Issue Threatens 15 Zometa Suits in NJ (subscription required)
- 23andMe Hit with False Ad Suit Over DNA Tests (subscription required)
- Diageo Shells Out $81M to Settle Aussie, NZ Thalidomide Suits (subscription required)
- Generic-Reglan Suits Doomed by Catch-22, 6th Circ. Says (subscription required)
- J&J
Continue reading...
Litigation
Continue reading...
- Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide
- Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required)
- Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required)
- Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine
- Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required)
- OxyElite Pro Class Action Filed Over False Advertising
- First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014
- J&J Takes Innovative,
Continue reading...
Litigation
Continue reading...
- Remicade Lawsuit Filed Over Nerve Paralysis, Breathing Problems
- GNC Hit with Suit Linking Supplement to Hepatitis (subscription required)
- J&J to Pay $2.5B to Settle Hip Implant Litigation (subscription required)
- $25M Hydroxycut Settlement Denied in False Ad MDL (subscription required)
- J&J Unit Hit with Suit Over Rheumatoid Arthritis Drug (subscription required)
- AMS Pelvic Organ Prolapse Mesh Lawsuit Set for Trial in August 2014
- 8th Circ. Returns Boston Scientific Mesh Suits to Fed. Court (subscription required)
- 3rd Cir. Affirms Plavix
Continue reading...